vidarabine has been researched along with African Lymphoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, HN; Hesseling, P; Israëls, T; Molyneux, EM; van de Wetering, MD; van Geloven, N | 1 |
| Almazi, JG; Christopherson, RI; Crossett, B; Kohnke, PL; Mactier, S | 1 |
| Amadori, S; Bruno, A; Buccisano, F; Cox, MC; Degan, M; Del Poeta, G; Del Principe, MI; Gattei, V; Marini, R; Maurillo, L; Panetta, P; Suppo, G; Venditti, A | 1 |
| Gadre, SA; Ge, Y; Lockhart, LH; Northup, JK; Velagaleti, GV | 1 |
| Christopherson, RI; Henrich, S | 1 |
| Banerji, V; Gibson, SB; Hu, X; Johnston, JB; Mendoza, FJ; Sun, J | 1 |
| Cohen, T; Manor, D; Margalith, M | 1 |
| Ogra, PL; Wong, DT | 1 |
| Coker-Vann, M; Dolin, R | 1 |
| Schilling, PJ | 1 |
| Abb, J | 1 |
2 review(s) available for vidarabine and African Lymphoma
| Article | Year |
|---|---|
Viral infections in immunocompromised patients.
Topics: Acyclovir; Adult; Antiviral Agents; Burkitt Lymphoma; Chickenpox; Child; Cytomegalovirus Infections; Disease Susceptibility; Enterovirus Infections; Herpes Simplex; Herpes Zoster; Humans; Immunologic Deficiency Syndromes; Immunosuppression Therapy; Infectious Mononucleosis; Orthomyxoviridae Infections; Respirovirus Infections; Vidarabine; Virus Diseases | 1983 |
[Prevention and therapy of herpesvirus infections].
Topics: Acyclovir; Antiviral Agents; Burkitt Lymphoma; Chickenpox; Cytomegalovirus; Cytomegalovirus Infections; Female; Herpes Genitalis; Herpes Simplex; Herpes Zoster; Herpesviridae; Herpesviridae Infections; Herpesvirus 3, Human; Herpesvirus 4, Human; Humans; Immunity, Cellular; Immunization, Passive; Infectious Mononucleosis; Male; Nasopharyngeal Neoplasms; Simplexvirus; Smallpox Vaccine; T-Lymphocytes; Vidarabine | 1985 |
9 other study(ies) available for vidarabine and African Lymphoma
| Article | Year |
|---|---|
Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Comorbidity; Drug Administration Schedule; Female; Humans; Hydrocortisone; Incidence; Injections, Intravenous; Malawi; Male; Malnutrition; Methotrexate; Neutropenia; Prospective Studies; Survival Rate; Treatment Outcome; Vidarabine | 2009 |
Fludarabine and cladribine induce changes in surface proteins on human B-lymphoid cell lines involved with apoptosis, cell survival, and antitumor immunity.
Topics: Antigens, CD; Apoptosis; B-Lymphocytes; Burkitt Lymphoma; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Survival; Cladribine; Drug Resistance, Neoplasm; Flow Cytometry; Glycoproteins; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Membrane Proteins; Reproducibility of Results; Signal Transduction; Up-Regulation; Vidarabine | 2012 |
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia.
Topics: ADP-ribosyl Cyclase 1; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Burkitt Lymphoma; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Humans; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Immunophenotyping; In Situ Hybridization, Fluorescence; Interphase; Life Tables; Male; Middle Aged; Neoplasm Proteins; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Solubility; Tumor Suppressor Protein p53; Vidarabine; ZAP-70 Protein-Tyrosine Kinase | 2004 |
Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Chromosomes, Human, Pair 8; Chromosomes, Human, X; Clone Cells; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Female; Genes, myc; Humans; Karyotyping; Lymph Nodes; Lymphoma, AIDS-Related; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Mutagenesis, Insertional; Pleural Effusion, Malignant; Prednisone; Rituximab; Translocation, Genetic; Trisomy; Vidarabine; Vincristine | 2007 |
Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; DNA Damage; Drug Resistance, Neoplasm; Genes, p53; Humans; Isoelectric Point; Leukemia, Lymphocytic, Chronic, B-Cell; Molecular Weight; Mutation; Neoplasm Proteins; Peptide Fragments; Peptide Hydrolases; Phosphorylation; Protein Processing, Post-Translational; Protein Structure, Tertiary; Tumor Suppressor Protein p53; Vidarabine | 2008 |
Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies.
Topics: Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoproliferative Disorders; Lysophospholipids; Multiple Myeloma; Mutagens; NF-kappa B; RNA, Messenger; Vascular Endothelial Growth Factor A; Vidarabine | 2008 |
Cytotoxicity of arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine to Epstein-Barr virus producer and nonproducer lymphoma cells in culture.
Topics: Adenine; Animals; Burkitt Lymphoma; Callitrichinae; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Genes, Viral; Herpesvirus 4, Human; Humans; Infectious Mononucleosis; Neoplasms, Experimental; Vidarabine | 1983 |
Effect of adenine arabinoside on Epstein-Barr virus in vitro.
Topics: Antigens, Viral; Burkitt Lymphoma; Capsid; Cell Division; Cell Line; Herpesvirus 4, Human; Idoxuridine; Vidarabine; Virus Replication | 1977 |
Two views of the immunologic effects of fludarabine.
Topics: Antineoplastic Agents; Burkitt Lymphoma; CD4-Positive T-Lymphocytes; Humans; Immunologic Deficiency Syndromes; Leukemia, Lymphocytic, Chronic, B-Cell; T-Lymphocytes, Regulatory; Vidarabine | 1991 |